glutathione reducing agent responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics | Discover Oncology With its potent antioxidant properties Toxicity of Glutathione-Binding Metals: A

Andrew Huberman: But the point that you're making is a really good one, that the four gram amount is not a threshold based on anything, except the threshold of people's willingness to actually take the stuff

Drug-induced cholestasis

Research in humans is a bit less impressive Clinical trials in humans A 1981 double-blind study found that chronic insomniac patients found that subjects slept 59% more, shorter sleep latency, and higher sleep efficiency (Schneider 1981) A 1987 double-blind study did not find any statistically significant changes in sleep structure as measured by REM sleep, NREM sleep, or total sleep time (Debellis 1987) A 1992 double-blind study in 14 chronic insomnia patients found higher sleep efficiency and subjectively estimated tiredness decreased to similar levels of healthy subjects in 7 nights of injections (Schneider 1992) There are some limitations to these studies however

Wilsons Disease represents an absolute contraindication

All of these put a demand on the body for glutathione